Chewing Clopidogrel in Addition to Regular Oral Clopidogrel Treatment to Improve Platelets Aggregation in Patient With NON ST ELEVATION MI

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE3

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2009-04-30

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Since the absorption of clopidogrel through the gastrointestinal tract is limited, we want to examine whether adding clopidogrel by chewing will overcome the limited gastrointestinal absorption, and hence will improve the prevention of platelet aggregation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Food Effect Study on Pharmacodynamic and Bioavailability of Clopidogrel 300/75 mg in Healthy Subjects

NCT01129271

Healthy

COMPLETED PHASE1

Clopidogrel Resistance in Stroke Patients From Different Ethnicities

NCT03806894

Clopidogrel, Poor Metabolism of Ischemic Stroke

UNKNOWN

Clopidogrel Reloading in Clopidogrel Resistant Patients With ACS

NCT00444132

Clopidogrel Non-Responsiveness

COMPLETED PHASE3

Effect of Different Dosing Regimens of Clopidogrel Before Elective Percutaneous Coronary Intervention (PCI) on Platelet Function

NCT00693069

Coronary Artery Disease

COMPLETED PHASE3

Platelet Reactivity in Stent Thrombosis Patients

NCT01012544

Coronary Artery Stent Thrombosis

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Platlet Aggregation Major Bleeding Outcomes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

clopidogrel by chewing

Group Type EXPERIMENTAL

clopidogrel by chewing

Intervention Type DRUG

600 mg clopidogrel by chewing

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

Placebo p.o

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

clopidogrel by chewing

600 mg clopidogrel by chewing

Intervention Type DRUG

Placebo

Placebo p.o

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male and Female older than 18 years old with non-ST myocardial infarction

Exclusion Criteria

* Current treatment with anticoagulation medication, any type of cerebro vascular event in the past, active bleeding, active peptic ulcer disease, pregnant women, any inability to sign an informed consent of participate in the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No